Download the app
Pfizer and BioNTech’s COVID-19 vaccine appears to be the first to obtain emergency use approval in the United States and Europe, and the company has announced its source and distribution plans.
Pfizer CEO Albert Bourla wrote an open letter stating that the vaccine, if it works and is safe, is likely to be sent to the US Food and Drug Administration. But it’s not the first time In the third week of November, review with the European Medicines Agency.
“He has a perfect profile and I have this vaccine . . . almost the best, and has an almost perfect profile,” BioNTech CEO and co-founder Ugur Sahin told CNN.
Pfizer and BioNTech BNT162b2 triggers the production of dominant neutralizing antibodies and T cells that target COVID-19 (SARS-CoV-2). A mixture of an antibody and a T-cell reaction is ideal for coverage against viral infection and disease.
When emergency use authorization is granted, Pfizer aims to send 7. 9 million doses of the COVID-19 vaccine per day. Hundreds of thousands of doses are already in Pfizer’s warehouses in the United States and Europe.
The plan focuses on distribution sites in Kalamazoo, Michigan and Puurs, Belgium, where the company will load temperature-controlled, constantly controlled reusable boxes on a total of 24 trucks on a constant basis. Kalamazoo is Pfizer’s largest production site. BioNTech has a higher production capacity in two of its facilities in Germany.
Pfizer mNR-based COVID-19 vaccine doses should be maintained close to -100 degrees F (-73. 33 degrees C). To do this, Pfizer has designed suitcase-sized shipping boxes that will keep vaccine doses at extremely cold temperatures for 10 days. Each temperature-controlled package comprises between 1000 and 5000 doses, the Wall Street Journal reported.
Pfizer aims to acquire a shipping area on an average of 20 aircraft according to FedEx Day, UPS and DHL International to send doses of vaccines to places as close as you can imagine to vaccination sites, such as giant hospitals or medical centers.
The carriers will then be there to transport the doses from the airports to those sites. In total, Pfizer expects deliveries to take 3 days.
Pfizer had stated in the past that it had decided on sites in Kalamazoo, Andover, Massachusetts and St Louis for its American production of COVID-19. Pfizer expects to deliver a hundred million doses of vaccine by 2020 and 1. 3 billion next year. to distribution centers in Kalamazoo and Puurs, Pfizer has sites in Wisconsin and Germany for more workshops to prepare them for shipping.
Pfizer has signed contracts of origin with the United States for one hundred million doses, with the option of an accumulation of 500 million It has an agreement with Europe for up to three hundred million doses, Japan (120 million) and the United Kingdom (30 million). Countries in South America and the Asia-Pacific region also placed important requests.
In the developments of the COVID-19 vaccine, a volunteer, a 28-year-old man, taking a placebo in a clinical trial of the COVID-19 vaccine developed through AstraZeneca and the University of Oxford, died, announced on Wednesday the Brazilian National Health Surveillance Agency. The trial continues.
The US Phase 3 trials are in the process of the U. S. And European Union’s Phase 3 trials. UU. de COVID-19 vaccine evolved through AstraZeneca and Oxford University and the vaccine evolved through Johnson
The coronavirus pandemic appears to be declining, with 20 European countries recording a record number of cases shown of COVID-19 on Wednesday. The UK had the highest, a new record of 26,668 new cases. New records were set in Italy (15199). ), Czech Republic (11984), Poland (10040), Netherlands (8500), Ukraine (6719), Switzerland (5596), Romania (4848), Slovakia (2202), Armenia (Armenia (2202), Armenia (2202), Armenia (2202), Armenia (2202), Armenia (2202), Armenia (2802), Armenia (2802), Armenia (2802), Armenia (2802), 1836), Slovenia (1503), Croatia (1424), Bulgaria (1336), Greece (865), Bosnia and Herzegovina (728), Belarus (733), Northern Macedonia (640), Luxembourg (430) Lithuania (311) and Latvia (188).
CEO mag is more than an advertising title; It is a source of information, inspiration and motivation for the world’s greatest success of leaders, leaders, investors and entrepreneurs. Our content creates conversations, our voice is the one that matters.